These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 35679154)
21. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation]. Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966 [TBL] [Abstract][Full Text] [Related]
22. Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience. Sestili S; Eder S; Belhocine R; Dulery R; Battipaglia G; Brissot E; Mediavilla C; Banet A; van de Wyngaert Z; Paviglianiti A; Ledraa T; Bonin A; Mohty M; Malard F Cytotherapy; 2020 Aug; 22(8):445-449. PubMed ID: 32434750 [TBL] [Abstract][Full Text] [Related]
23. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease. Bisaccia E; Palangio M; Gonzalez J Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415 [TBL] [Abstract][Full Text] [Related]
24. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo. Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297 [TBL] [Abstract][Full Text] [Related]
25. Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease. Franklin C; Cesko E; Hillen U; Schilling B; Brandau S PLoS One; 2015; 10(8):e0134518. PubMed ID: 26241482 [TBL] [Abstract][Full Text] [Related]
26. A Prospective, Multicenter Study of Closed-System Extracorporeal Photopheresis for Children with Steroid-Refractory Acute Graft-versus-Host Disease. Kitko CL; Abdel-Azim H; Carpenter PA; Dalle JH; Diaz-de-Heredia C; Gaspari S; Gennery AR; Handgretinger R; Lawitschka A Transplant Cell Ther; 2022 May; 28(5):261.e1-261.e7. PubMed ID: 35124293 [TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621 [TBL] [Abstract][Full Text] [Related]
28. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Flowers ME; Apperley JF; van Besien K; Elmaagacli A; Grigg A; Reddy V; Bacigalupo A; Kolb HJ; Bouzas L; Michallet M; Prince HM; Knobler R; Parenti D; Gallo J; Greinix HT Blood; 2008 Oct; 112(7):2667-74. PubMed ID: 18621929 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537 [TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report. Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848 [TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis for the treatment of chronic graft versus host disease. Kansu E; Ward D; Sanchez AP; Cunard R; Hayran M; Huseyin B; Vaughan M; Ku G; Curtin P; Mulroney C; Costello C; Castro JE; Wieduwilt M; Corringham S; Ihasz-Davis A; Nelson C; Ball ED Hematology; 2022 Dec; 27(1):785-794. PubMed ID: 35802815 [TBL] [Abstract][Full Text] [Related]
32. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Jagasia M; Scheid C; Socié G; Ayuk FA; Tischer J; Donato ML; Bátai Á; Chen H; Chen SC; Chin T; Boodée H; Mitri G; Greinix HT Blood Adv; 2019 Jul; 3(14):2218-2229. PubMed ID: 31332045 [TBL] [Abstract][Full Text] [Related]
33. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults. Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135 [TBL] [Abstract][Full Text] [Related]
34. Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden. Schain F; Boissin C; Laczik T; Fedeli S; Remberger M; Blennow O; Dykes J; Eich T; Jones C; Mattsson J; Berlin G Transfus Apher Sci; 2023 Jun; 62(3):103705. PubMed ID: 36967367 [TBL] [Abstract][Full Text] [Related]
35. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819 [TBL] [Abstract][Full Text] [Related]
36. [Extracorporeal photopheresis in treatment of chronic graft versus host disease]. Bojanić I; Seiwerth RS; Mazić S; Dubravcić K; Batinić D; Cepulić BG; Labar B Lijec Vjesn; 2013; 135(5-6):139-44. PubMed ID: 23898694 [TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452 [TBL] [Abstract][Full Text] [Related]
38. Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain. Boluda B; Solana-Altabella A; Cano I; Acuña-Cruz E; Rodríguez-Veiga R; Ballesta-López O; Megías-Vericat JE; Martínez-Cuadrón D; Gómez I; Solves P; Lorenzo I; Piñana JL; Sanz J; Guerreiro M; Montoro Gómez J; Díaz-González A; Marco J; Blanco A; Sanz MÁ; Montesinos P J Clin Apher; 2021 Aug; 36(4):612-620. PubMed ID: 33964038 [TBL] [Abstract][Full Text] [Related]
39. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Peinemann F; Bartel C; Grouven U Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658 [TBL] [Abstract][Full Text] [Related]
40. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects. Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A Front Immunol; 2018; 9():2207. PubMed ID: 30349527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]